# FDA 483 - PLZ Corp - December 22, 2022

Source: https://www.keypedia.com/records/483/plz-corp/57429afc-2744-41f2-b14a-3947e4680375

> FDA 483 for PLZ Corp on December 22, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: PLZ Corp
- Inspection Date: 2022-12-22
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of 220 Laboratories, LLC in Riverside, CA, revealed significant deficiencies in their quality control and manufacturing practices. The firm failed to thoroughly investigate numerous customer complaints and out-of-specification environmental monitoring results, including mold contamination. Additionally, the quality unit did not ensure proper batch record calculations, and employees lacked up-to-date GMP training.

## Related Officers

- [Cecilia H. Kieu](https://www.keypedia.com/people/cecilia-h-kieu/3ba5feb0-d49e-4301-ae5c-b84bd604a159)

Company: https://www.keypedia.com/companies/plz-corp/c12286c0-ab29-4ea7-82c7-e402764afab2

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6